• Corpus ID: 35297127

Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.

  title={Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.},
  author={Ursula Gresser and Christoph H. Gleiter},
  journal={European journal of medical research},
  volume={7 10},
Since introduction of the PDE-5 inhibitor sildenafil 4 years ago, there has been a fundamental change in the treatment of erectile dysfunction (ED). Intracavernosal or intraurethral injections of vasoactive substances or penile implants as mechanical aids now play hardly any part in it. - The development of the PDE-5 inhibitors vardenafil and tadalafil prompts the question of whether and how these three substances differ in terms of their efficacy and adverse effects. - Sildenafil has proven to… 

Figures and Tables from this paper

Advances in the Treatment of Erectile Dysfunction: A Focus on Tadalafil

Tadalafil has a therapeutic duration of up to 36 hours that may allow patients to engage in sexual activity at their own convenience rather than in a limited time period, which should make it an attractive alternative to currently available treatments options.

Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction.

Tadalafil represents an effective and safe long-term option for SCI patients with ED and shows a significant statistical improvement in erectile function, sexual satisfaction, overall satisfaction and percentages of "yes" responses to the SEP2-3 compared with baseline using the Wilcoxon test.

Vardenafil for the treatment of erectile dysfunction

An improvement in sexual function seems to contribute to quality of life and improve satisfaction in couples and its tolerability and safety profile is acceptable, with headaches, flushing, rhinitis and dyspepsia being the major reported side effects.

Predictors of tadalafil efficacy in men with erectile dysfunction: the SURE study comparing two dosing regimens.

On-demand and three-times-per-week dosage regimens of tadalafil 20 mg were equally efficacious in men with erectile dysfunction and baseline disease severity scores were the strongest predictors of efficacy endpoint scores.

Efficacy of sildenafil as the first-step therapeutic tool for Japanese patients with erectile dysfunction

Sildenafil citrate may be recommended as the first choice drug for ED because of its high success rate and low invasiveness.

Phosphodiesterase 5 inhibitors in male sexual dysfunction

  • A. Kuthe
  • Medicine
    Current opinion in urology
  • 2003
In the future, in addition to sildenafil, the new phosphodiesterase 5 inhibitors vardenafil and tadalafil will play an important role in the management of erectile dysfunction, depending on the patient's health profile.

[Drug therapy of erectile dysfunction--the current status].

In the medicinal therapy of erectile dysfunction, both oral as well as local application are possible, and the intra-cavernosal pharmacotherapy with PGE(1) is considered the gold standard when oral therapies do not work or can not be used.

Topical alprostadil cream for the treatment of erectile dysfunction

  • E. Becher
  • Medicine
    Expert opinion on pharmacotherapy
  • 2004
Alprostadil topical cream is a potential first-choice alternative for ED in patients who do not respond or who cannot tolerate or do not accept PDE-5 inhibitor therapy, as well as in otherwise healthy ED patients.

Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction

Tolerability and safety in cardiovascular patients seems to be good with no significant increase in cardiovascular events that could be directly attributed to the pharmacologic agent, and special caution is mandatory if vardenafil is administered in combination with α-blockers, as significant hypotension might occur.



Long-term efficacy and safety of oral Viagra® (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal

In men with ED of psychogenic or mixed organic/psychogenic aetiology, oral sildenafil is effective and well-tolerated both at the initiation of therapy and during long-term treatment.


Oral sildenafil is an effective, welltolerated treatment for men with erectile dysfunction and is associated with improved erectile function in the dose–response study.

Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors.

Clinicians should be particularly careful to evaluate patients presenting with ED because the condition can be accompanied by a wide spectrum of risk factors requiring monitoring and treatment, and with adequate treatment and control of these risk factors, the use of sildenafil in a representative population of men with ED in a multispecialty clinic can achieve a higher efficacy rate than previous studies have indicated.

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

Vardenafil treatment resulted in a high efficacy and low adverse-event profile in a population with mixed ED etiologies and improved all IIEF domains compared to placebo.

Three-year update of sildenafil citrate (Viagra) efficacy and safety.

Accounts of sildenafil use in clinical practice and postmarketing data reflect clinical trial findings of effectiveness in a broad spectrum of ED aetiologies and overall good tolerability.

Onset and duration of action of sildenafil for the treatment of erectile dysfunction.

Sildenafil is an effective oral treatment for ED that produces a penetrative erection as early as 12 min and for most patients, within 30 min after dosing, and a duration of action lasting at least 4 h.

On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunction

The conclusion of this study was that on-demand IC351 at doses up to 25 mg was well tolerated and significantly improved erectile function.

Current treatments and emerging therapeutic approaches in male erectile dysfunction

The high prevalence of ED, in conjunction with the extensive media coverage of the availability of sildena®l as the ®rst effective oral treatment available, may lead to more patients seeking treatment for ED, and the responsibility for the clinical management of such patients has consequently broadened to become multidisciplinary.

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Sildenafil is shown to enhance the erectile response (duration and rigidity of erection) to visual sexual stimulation, thus highlighting the important role of PDE5 in human penile erection.